5/28
09:00 am
igc
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
Low
Report
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
5/21
02:00 pm
igc
IGC Pharma to Attend BIO International Convention 2024
Low
Report
IGC Pharma to Attend BIO International Convention 2024
4/16
07:00 am
igc
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
Medium
Report
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
4/9
09:00 am
igc
IGC Pharma Adds Advisor in Artificial Intelligence
High
Report
IGC Pharma Adds Advisor in Artificial Intelligence
3/26
03:00 pm
igc
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
Low
Report
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
3/20
11:00 am
igc
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
Medium
Report
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
3/20
07:00 am
igc
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Low
Report
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
3/12
03:00 pm
igc
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
Low
Report
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline